Ocado推出了一个重量管理通道,配有高蛋白、低卡路里食品,用GLP-1药物支持英国的购物者。 Ocado launched a weight management aisle with high-protein, low-calorie foods to support UK shoppers using GLP-1 medications.

奥卡多(Ocado)在英国启动了一个“体重管理”通道, 以小型、高蛋白质、低卡路里食物为主, Ocado has launched a "weight management" aisle in the UK featuring smaller, high-protein, low-calorie foods like a 100g extra-lean steak, cottage cheese, and ready-to-drink protein meals, targeting consumers using GLP-1 weight loss medications. 这项举措是在Marks & Spencer和Waitrose等零售商作出类似努力之后采取的,预计到2025年7月,将有多达250万英国成年人使用这些药物。 The move follows similar efforts by retailers such as Marks & Spencer and Waitrose, as up to 2.5 million UK adults were expected to use these drugs by July 2025. Ocado的研究发现,22%的购物者认为是治疗,在25至34岁的25至34岁者中,这一比例上升到37%,尽管只有40%的人了解药物是如何起作用的。 Ocado research found 22% of shoppers considered the treatment, rising to 37% among 25- to 34-year-olds, though only 40% understood how the drugs work. 超过70%的人说,他们希望获得有关食物的指导,以便在减肥期间保持肌肉。 Over 70% said they want guidance on foods that preserve muscle during weight loss. 1月初,蛋白质主食销售量猛增,家庭乳酪增加138%,牛排增加63%,反映出对营养平衡的替代方案的需求日益增加,以支持医疗体重下降。 Sales of protein staples surged in early January, with cottage cheese up 138% and steak 63% higher, reflecting growing demand for nutritionally balanced options to support medical weight loss.